IIA
GSK icon

IPG Investment Advisors’s GSK GSK Stock Holding History

IPG Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,896
Closed -$363K – 149
2017
Q1 		$363K Sell
6,896
-1,200
-15% -$60.9K 0.16% 82
2016
Q4 		$390K Buy
8,096
+1,200
+17% +$59.3K 0.16% 79
2016
Q3 		$372K Hold
6,896
– – 0.16% 77
2016
Q2 		$374K Hold
6,896
– – 0.15% 83
2016
Q1 		$350K Hold
6,896
– – 0.16% 73
2015
Q4 		$351K Buy
6,896
+2,000
+41% +$102K 0.16% 76
2015
Q3 		$235K Hold
4,896
– – 0.11% 104
2015
Q2 		$255K Buy
4,896
+896
+22% +$50.4K 0.09% 110
2015
Q1 		$231K Buy
+4,000
New +$229K 0.09% 109

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IPG Investment Advisors's GSK Position: Q2 2017 in Review

IPG Investment Advisors sold out of GSK (GSK) in Q2 2017, closing a stake of 6,896 shares — an estimated $363K sold.

IPG Investment Advisors first reported a position in GSK in Q1 2015 and held it in 9 quarters. The position peaked at $390K in Q4 2016. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • IPG Investment Advisors reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
  • IPG Investment Advisors sold 6,896 GSK shares in Q2 2017, an estimated $363K.
  • IPG Investment Advisors first reported a position in GSK in Q1 2015 and held it in 9 quarters.
  • IPG Investment Advisors's GSK position peaked at $390K in Q4 2016.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on IPG Investment Advisors's 13F filing for Q2 2017, filed 28 Jul 2017.